/Adsense//

Introduction: Understanding Thymoma

Thymoma is a tumour that arises from the thymus gland, a small gland located in the upper chest just behind the breastbone (sternum). The thymus gland plays a key role in the development of the immune system during childhood. In adults, it usually shrinks but can sometimes develop abnormal cell growth, leading to formation of a tumour called thymoma.

Although many thymomas are slow growing, they must be taken seriously because they can invade nearby structures or, over time, become more aggressive.

Why Thymoma Develops

The exact cause of thymoma is not fully understood, but it arises when certain cells of the thymus begin to grow uncontrollably. This is not something patients do or do not do; it is usually not linked to lifestyle factors.

The thymus helps teach the body’s immune cells (T-cells) to distinguish between “self” and “foreign” substances. Abnormal growth in the thymus can sometimes confuse the immune system, contributing to autoimmune disorders such as Myasthenia Gravis (MG)..

Symptoms & Warning Signs

Many patients have no symptoms. Thymoma is often discovered incidentally during a chest X-ray or CT scan done for another reason.

When symptoms occur, they may include:

  • Persistent chest heaviness or pressure
  • Shortness of breath or cough
  • Hoarseness of voice
  • Difficulty swallowing
  • Facial or neck swelling (due to pressure on major veins – superior vena cava syndrome)
  • Fatigue or weakness (especially if associated with Myasthenia Gravis)

Thymoma & Its Association with Myasthenia Gravis (MG)

  • About 30–40% of thymoma patients also have MG.
  • Conversely, 10–15% of MG patients have a thymoma.
  • MG is an autoimmune neuromuscular disorder that causes muscle weakness, droopy eyelids (ptosis), difficulty speaking, chewing, or even breathing in severe cases.
  • In patients with both thymoma and MG, removal of the thymus gland (thymectomy) often improves or stabilises MG symptoms.

Early evaluation by a thoracic surgeon is crucial in such cases to ensure both the tumour and the autoimmune component are properly addressed.

Why Thymoma Should Not Be Ignored

A common myth is that a “small” or asymptomatic thymoma can be safely left alone. This is not true. Even small thymomas may:

  • Gradually enlarge and press on vital chest structures
  • Invade surrounding tissues like the lungs, heart covering (pericardium), or major blood vessels
  • Transform into thymic carcinoma, which is more aggressive and harder to treat

Timely surgery offers the best chance of cure and prevents complications.

How Thymoma is Diagnosed

Imaging Studies

  • Contrast-enhanced CT scan of the chest is the main test.
  • MRI helps when the tumour’s relationship to blood vessels or the heart needs better assessment.
  • PET-CT may be used to check for disease spread in some cases.

Blood Investigations

Routine blood investigations may be required to asses the patient’s fitness for undergoing treatment.

Apart from the routine investigations AChR-Antibody test may be ordered to look for myasthenia gravis

Other tests

Certain other tests may be required to rule out conditions that may be associated with Thymoma like:

  • Myasthenia gravis.
  • Acquired pure red cell aplasia.
  • Hypogammaglobulinemia.
  • Polymyositis.
  • Lupus erythematosus.
  • Rheumatoid arthritis.
  • Thyroiditis.
  • Sjögren syndrome.

Biopsy Considerations

  • If the tumour is clearly resectable (removable by surgery) on imaging, a pre-operative biopsy is usually avoided to prevent seeding of tumour cells.
  • Biopsy is reserved for cases where the tumour appears unresectable or has spread.

Staging

Doctors often describe thymoma using:

  • Masaoka-Koga Staging: based on how far the tumour has invaded surrounding tissues.
  • TNM Staging:Tumour size/extent (T), Node involvement (N), and distant spread (M).

Your surgeon will explain the stage in simple terms and how it affects treatment decisions.

What are the stages of Thymoma?

Thymoma is categorized into different stages based on the extent of tumor spread. The Modified Masaoka-Koga staging system is commonly used to determine the appropriate treatment plan and prognosis. Here’s a detailed explanation of each stage:

Stage I: Encapsulated Thymoma
robotic-thymec-post

Description: The tumor is completely encapsulated and confined within the thymus. It has not spread to surrounding tissues or organs.

Stage IIA: Microscopic Invasion into Surrounding Fatty Tissue
robotic-thymec-post

Description: The tumor shows microscopic transcapsular invasion into the surrounding fatty tissue that is not appreciated grossly and is only visible under microscope.

Stage IIB: Macroscopic Invasion into Surrounding Fatty Tissue or Pleura
robotic-thymec-post

Description: Description: The tumour exhibits macroscopic (grossly visible) invasion into the surrounding fatty tissue and may be touching the pleura but not invading through it.

Stage III: Invasion into Neighbouring Organs
robotic-thymec-post

Description: The thymoma has invaded neighbouring organs such as the pericardium (heart lining), lungs, or major blood vessels.

Stage IVA: Pleural or Pericardial Dissemination
robotic-thymec-post

Description: The tumor has spread to the pleural or pericardial surfaces, leading to multiple tumor nodules in these areas.

Stage IVB: Lymphogenous or Hematogenous Metastasis
robotic-thymec-post

Description: The thymoma has spread to distant lymph nodes or other organs via the bloodstream.

Treatment Options

Surgery – The Cornerstone

For localised and resectable thymomas, complete surgical removal (thymectomy) is the standard and most effective treatment.

  • When thymoma is completely removed, cure rates are high and long-term survival is excellent.
  • For advanced or invasive thymomas, surgery is often combined with radiation therapy and sometimes chemotherapy.

Multidisciplinary Care

At Medanta Hospitals, thymoma patients are treated by a team of thoracic surgeons, neurologists, oncologists, anaesthetists, and ICU specialists, ensuring comprehensive care tailored to each patient.

Surgical Approaches to Thymectomy

  1. Traditional Open Sternotomy
    • Involves splitting the breastbone for wide access
    • Still used in very large or invasive tumours
    • More painful, longer recovery, and larger scar
  2. Minimally Invasive Thoracoscopic (VATS) Thymectomy
    • Performed through small incisions with video-assisted instruments
    • Less painful and faster recovery than sternotomy
  3. Robotic Thymectomy – The Modern Standard
    • Performed using the da Vinci® Robotic System or similar platforms
    • Offers 3-D, high-definition magnified view and exceptional precision
    • Less pain, smaller scars, shorter hospital stay, and quicker return to normal activities
    • robotic-thymec-post

Dr Belal Bin Asaf’s Expertise in Robotic Subxiphoid Thymectomy

Dr Belal Bin Asaf is among the most experienced robotic thoracic surgeons in India and performed India’s first robotic subxiphoid thymectomy.

Advantages of the Subxiphoid Approach

  • Single small incision below the breastbone
  • Excellent cosmetic outcome (hidden scar)
  • Direct access to the entire thymus and surrounding fat – essential in MG
  • Less post-operative pain and faster recovery

Many patients can return home within 3–4 days of surgery.

Recovery & Long-Term Outcomes

  • Hospital stay:usually 3–5 days for minimally invasive/robotic surgery
  • Return to daily activities: within 2–3 weeks
  • Recurrence risk: low when the tumour is completely removed and surgery is performed by an experienced thoracic surgeon
  • MG patients often experience improvement in symptoms over months to years

Stage-wise treatment of Thymoma

Stage 1

Surgery is typically the best treatment option for Stage I thymomas. Complete surgical resection results in excellent long-term outcomes. Most tumours in this stage can be managed by minimally invasive chest surgery like Robotic Thymectomy or VATS /Thoracoscopic Thymectomy.

Prognosis: Patients diagnosed at this stage generally have a favorable prognosis with high long term survival rates.

Stage 2a

urgery is still highly efficacious and the primary treatment. Complete surgery can still be achieved by Robotic surgery or Thoracoscopic surgery in many patients.

Prognosis:Prognosis remains good, with a high likelihood of successful treatment and long-term survival.

Stage 2b

Surgical resection is the mainstay of treatment, often may be followed by radiotherapy to address any remaining cancer cells and prevent recurrence.

Prognosis: The prognosis is slightly less favourable than Stage I and IIA but still generally positive with appropriate treatment. Completeness of tumour removal plays a major role in the outcome, and hence, an experienced surgical team should address such cases. In experienced hands, a significant proportion of such patients can be managed by robotic thymectomy

Stage 3

Surgery is more complex and may involve removing parts of invaded organs. This is usually followed by radiotherapy and sometimes chemotherapy, especially if complete resection is not possible. Evaluation of such patients by a high-volume surgical team is very important as many of these cases can still be treated by surgery; however, the probability of robotic surgery is reduced. If the tumour is adherent to only the pericardium (lining of the heart) and/or a small portion of the adjacent lung, it can be managed by minimally invasive technique. Robotic surgery is better suited in such cases due to increased dexterity and precision.

Prognosis: Prognosis varies depending on the extent of invasion and the success of the surgical resection. Multimodal treatment improves outcomes. With complete removal of the tumour by experienced surgical team can give best outcomes in in some locally advanced cases.

Stage 4a

Stage 4a Thymomas are treated by a combination of surgery, chemotherapy, and radiotherapy. Many people think that surgery is not possible in cases of Thymoma that has spread to the pleura (lining of Lungs) of the pericardium (Lining of the heart). However, surgery is still very useful, where in the tumour is removed along with a complete removal of all nodules (achieved by total pleurectomy / pericardiectomy). In these cases some form of additional treatment in the form of adjuvant chemotherapy and radiation therapy is almost always required.

A form of chemotherapy which is given during surgery may also be used in selected patients. It is known as HITHOC. Hyperthermic Intrathoracic Chemotherapy (HITHOC) is an advanced treatment option for thymoma, especially in cases where the cancer has spread within the chest cavity. After surgical removal of the tumor, a heated chemotherapy solution is circulated within the chest cavity to eliminate any remaining cancer cells. The heat enhances the effectiveness of the chemotherapy, improving its ability to target and destroy cancer cells while minimizing side effects. HITHOC offers an innovative approach to reduce the risk of cancer recurrence and improve overall treatment outcomes. This innovative therapy is being done frequently by our team.

Prognosis: Prognosis is more guarded, and aggressive multimodal treatment is necessary to manage the disease. However relatively long survival has been reported by surgery along with other therapies.

Stage 4b

In stage 4b the disease has spread beyond the confines of thymus gland through blood and lymph. Local therapy alone in the form of surgery will not be sufficient. Systemic chemotherapy is typically the primary treatment approach, often combined with radiotherapy. Surgery may be considered in select cases to alleviate symptoms or manage localized disease.

Prognosis: Stage IVB represents advanced disease and the prognosis is not as good as in early stages.

Common Patient Concerns Addressed

  • Is surgery risky?

    Modern anaesthesia and minimally invasive techniques have made thymectomy safe and well-tolerated in most patients.

  • Will surgery spread the tumour?

    No – in fact, complete removal prevents spread. Careful surgical handling avoids any risk of tumour seeding.

  • Is robotic surgery safe?

    Yes – robotic systems are well-validated globally. Success depends on the surgeon’s expertise.

  • What if I delay surgery?

    Delays can allow the tumour to invade nearby structures, making surgery more difficult and outcomes less favourable.

FAQ – Thymoma & Thymectomy

Thymoma is usually low- to intermediate-grade cancer, meaning it grows slowly but can invade nearby tissues if untreated.

Thymic carcinoma is a rarer, more aggressive form of tumour that behaves more like traditional cancers and often requires combined therapy.

If the tumour is resectable, surgery is recommended for most patients. Some advanced cases may need chemotherapy or radiation first.

Removing the thymus can reduce the autoimmune attack on muscles, leading to symptom improvement or remission in many MG patients.

For most suitable cases, robotic thymectomy provides the best balance of precision, safety, and recovery benefits.

Yes. In experienced hands, robotic thymectomy is as safe as open surgery with less pain, quicker recovery, and better cosmetic results.

Most patients go home within 3–5 days and return to routine activities in 2–3 weeks.

The risk is low if the tumour is completely excised, but follow-up scans are essential for early detection if it happens.

Most patients spend 5–7 days in hospital after surgery. Recovery is faster with minimally invasive techniques like VATS or robotic surgery. Long-term, patients experience significant improvement in symptoms and resolution of hemoptysis.

If the aspergilloma is completely removed, recurrence is very rare. However, patients with underlying lung disease remain at risk for other complications and need regular follow-up.

If untreated, aspergilloma can lead to:
  • Recurrent or massive life-threatening hemoptysis
  • Chronic lung infections
  • Severe decline in quality of life

Aspergilloma surgery can be technically challenging because of dense adhesions and fragile blood vessels. However, in experienced thoracic surgery centers, surgical success rates are high with excellent long-term outcomes.

Still have questions about Aspergilloma and its treatment? Book a consultation with Dr. Belal Bin Asaf, one of India’s leading thoracic surgeons, for expert advice and personalized care.

Schedule Your Appointment Today

Internal & External Links

Do not delay seeking expert advice.

Early and complete removal of thymoma by a specialist thoracic surgeon gives the best chance for cure and improved quality of life.

If you or your loved one has been diagnosed with thymoma or Myasthenia Gravis, or if a chest scan has revealed a mass near the thymus gland:

Book an Appointment Today

Receive a comprehensive evaluation and a personalised treatment plan based on the latest evidence and advanced minimally invasive techniques.

Facing a diagnosis of thymoma can be stressful, but timely information and expert care make all the difference.

With modern robotic surgery and a dedicated multidisciplinary team, the outlook for most thymoma patients today is very positive.

You are not alone on this journey – compassionate, expert help is available.

Patient Information Video's

Video 1
Video 2
whatsapp-mobi
h-call
Appointment